What are the possible side effects of using bedaquiline/snare?

Bedaquiline (Bedaquiline) is an anti-tuberculosis drug that targets ATP synthase. Although it has shown significant efficacy in the treatment of multi-drug-resistant tuberculosis, it may also cause some unique adverse reactions due to its unique mechanism of action. It is important for patients to understand their potential side effects for appropriate use and safety monitoring.

The most common adverse reactions include fatigue, nausea, headache and joint pain. These symptoms are usually more obvious at the beginning of treatment and will gradually ease as the body adapts to the drug. Some patients may experience gastrointestinal discomfort, such as abdominal distension, loss of appetite or mild diarrhea during medication. It is recommended to take it with food to reduce gastric irritation.

It is worth noting that bedaquiline may cause electrocardiogramQT interval prolongation, which is one of the adverse reactions of this drug that needs to be monitored clinically. QT prolongation will increase the risk of arrhythmia, so patients should monitor their electrocardiogram regularly before and during medication, especially when combined with other drugs that may prolong the QT interval (such as moxifloxacin, clofazimine). Doctors usually adjust the medication rhythm or dosage based on monitoring results to ensure heart safety.

In addition, abnormal liver function is also one of the potential side effects of bedaquiline, manifested as elevated serum aminotransferases or mild jaundice. To reduce risks, patients should avoid drinking alcohol and taking other hepatotoxic drugs during treatment, and undergo regular liver function tests. Rare cases of rash or allergic reaction have been reported, and these conditions are generally mild and resolve after discontinuation of the drug.

In general, most of the adverse reactions of bedaquiline are controllable and reversible. Through monitoring and individualized adjustments under the guidance of doctors, the vast majority of patients can successfully complete the treatment course.

Reference materials:https://en.wikipedia.org/wiki/Bedaquiline